BioCrowd

Read articles on "Project Management And Change Control" @ http://www.blog.pharmasupport.in/ Get Events Details @ http://w... [read more]

An intersting research paper by Ohkawa et al. Although Viruses typically hitchhike around the cytoplasm on microtubules, Ohka... [read more]

http://www.youtube.com/watch?v=nmIIAH...

I came across an article at http://www.cell.com/abstract/S0092-86..., a paper by Zhang et al and I have a quest... [read more]

... Read all 11 comments ...

Erik Carter: Cool! I look forward to it (as always).

Agyeman-Badu Ken Yaw: Aahh soo sweet, TWiV #89 - Where do viruses vacation? is one of my best episodes, why? maybe because my e-mail was read and it answered my question accurately and I'm now satisfied,thanks Dr... [read more]

Joanna: maybe this will help or just extend your knowledge http://jvi.asm.org/cgi/content/full/7...

Recently I had interesting discussion with my dad about hand rubs and different formulas used in hand rubs. One of the main p... [read more]

I am interested to know if there is any member in this group who belongs to Biocatalysis researcher

This is directed to any of the biologists (microbiologists in particular) here on BioCrowd: What advice would you give an ... [read more]

Clifford Mintz: I think the best thing to do is take classes in microbiology, virology and related disciplines and then find a laboratory to do research in. This will introduce you to the life of a research... [read more]

Erik Carter: Thanks! Microbiology and Virology were definitely high on my list, and the virology professor at my school even recommended two courses called Gene Expression and, for my senior year, a grad... [read more]

Agyeman-Badu Ken Yaw: This is very good, i like it.

Do you think pharmaceutical and biotechnology companies ought to use social media to interact with their customers and stakeh... [read more]

Erik Carter: I think that would be a very good idea, especially for pharmaceutical companies because they have the reputation (mostly unfounded) in the public eye of being somehow corrupt. There's the te... [read more]

Vincent Racaniello: I cannot see why they would not. They are too insular and need to not only interact with customers, but feel their pulses. At the moment it's very expensive for them to do so (market surveys... [read more]

IndieOctopi: You know the saying "one bad egg spoils the bunch" applies to how the public regard pharmaceutical companies (and really any corporation). Anytime there is profit there will be corrupti... [read more]

On episode #91 of the podcast 'This Week in Virology', Vincent, Dickson, Alan, Rich and Welkin discuss the nature, origin, an... [read more]

I like this file

Laval Bio Symposium 2010 From Discovery to Clinical Trials Securing a Third Party Alliance We are pleased to invite y... [read more]

I like this file

We want to hear your opinion. How would you define success in science? Is success based solely on results?

... Read all 5 comments ...

Vincent Racaniello: For me, success in science means contributing to our understanding of life. That could be making a discovery, or training another scientist to make important discoveries.

Erik Carter: After rereading my answer it sounds harsher than I wanted it to. What I meant wasn't that in order to be successful in science to have to cure cancer or discover the Higgs Boson. By "impact"... [read more]

Clifford Mintz: Success as a scientist in traditional terms is almost exclusively results oriented and based on the "impact" that a person makes in his/her respective fields. However, in my experience,succe... [read more]

I had no idea that the website sciencedaily.com had an entire page just for virology news. I'm sure this will become one of t... [read more]

I like this file

Vincent Racaniello: It's a good site - we might have picked it on TWiV, but if not, we will. They should like to virology blog - but like many other such sites they are focused on themselves.

I have worked in labs in both an academic and commercial environment and have felt the frustration of working with antibodies... [read more]

I'm looking for information on companies that you can outsource compounds and cell lines for screening. Am also interested in... [read more]

Irene Gabashvili, PhD: High throughout screening at biotech-register.com: http://www.biotech-register.com/biote... Google directory of CROs: http://www.google.com/Top/Business/Bi...... [read more]

i am currently undertaking a research on selective breeding. i am mating a balb c(white male) mouse with a diabetic mouse(bla... [read more]

Agyeman-Badu Ken Yaw: From my point of view and a previous work done using a different animal model, the pregnant diabetic mouse will not give birth to one offspring but multiple offspring and from homologous rec... [read more]

ReGenesis is practically the best scientific based movie i have ever watched since God gave me breathe. It is a Canadian tele... [read more]

This paper published in the latest Science Magazine (July 8, 2010) puts forth the discovery of a 'broadly neutralizing human ... [read more]

I like this file

... Read all 9 comments ...

Agyeman-Badu Ken Yaw: Yahoo has a temporal problem so I'm having trouble attaching the file to the mail, but i traced it and got the website where it is located so that you can download and read. Its a nice paper... [read more]

Erik Carter: thank you so much. that should be fun to read. I love PLOS Pathogens, and I love that it's free access.

Agyeman-Badu Ken Yaw: Yes, i really do love PLOS Pathogens, research papers that come from there have a detailed write-up and i just love it when a paper is detailed.

Here is a website that is full of interesting interviews/discussions with people who have big ideas: scientists, authors, jou... [read more]

I like this file

Agyeman-Badu Ken Yaw: Nice website, really enjoyed the Health & Medicine section.

We use EBV to immortalize B-cells, and currently purchase the EBV from ATCC (VR-1492). To ensure consistancy in our runs, we... [read more]

Vincent Racaniello: Ryan, I'm looking into this for you.

Vincent Racaniello: Ryan, I would contact either Eliot Kieff at Harvard, Lori Frappier in Toronto, or Bill Sugden at Wisconsin. You can find their emails on any recent paper, just search in PubMed.

The biopharmaceutical company, Gilead Sciences, has taken the decision to close its research and development operations in Du... [read more]

Hi Dr.Vincent,why is Dr.Rich Condit not on Biocrowd? Just added Alan and Dick and can not find Rich.I admire him alot and i a... [read more]

Erik Carter: I agree. Rich, please come to BioCrowd!!!! Join the party. ^_^

Vincent Racaniello: I will tell Rich to join...I am sure he will.

Agyeman-Badu Ken Yaw: At long last, Dr. Rich Condit is now on biocrowd. I'm glad.

As reported by Thomson Reuters, investment in R&D within the pharmaceutical industry fell in 2009. Consequentially this has s... [read more]

OH my God, my country GHANA couldn't make history for poor Africa by reaching the semifinals. We are out of the world cup pla... [read more]

Erik Carter: awww. :'( ....I don't follow soccer/football. haha

Agyeman-Badu Ken Yaw: yeah,i guess i should follow your style.

INCENTER, my nonprofit, is developing a web-based matching platform for facilitating industry access to university labs, whic... [read more]

As reported by the Associated Press, the multinational biopharmaceutical company, Celgene has announced that it is planning t... [read more]

A research by Frank Buchholz of the Max Planck Institute for Cell biology and Genetics;he and his group have already cured a ... [read more]

I like this file

... Read all 7 comments ...

Erik Carter: I contacted Dr. Frank Buchholz and he sent me a copy of the full text. I'll send you the PDF through the email address you gave me earlier. ~Erik

Erik Carter: Actually, I've lost your email address. Can you send it to me again?

Agyeman-Badu Ken Yaw: kenzibit@yahoo.com You are the man.